Covered recipient · General Payments record
TAMMY K POPE
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2020–2024
$824.23
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $245.93 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $49.31 | 3 |
| GlaxoSmithKline, LLC. | $32.77 | 2 |
| Novo Nordisk AS | $31.08 | 2 |
| ITI, Inc. | $26.47 | 1 |
| PFIZER INC. | $24.37 | 1 |
| Abbott Laboratories | $21.65 | 1 |
| ABBVIE INC. | $15.89 | 1 |
| Axsome Therapeutics, Inc. | $15.63 | 1 |
| Nevro Corp. | $14.63 | 1 |
| Currax Pharmaceuticals LLC | $14.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.65 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125050602 | CMS |
| ABBVIE INC. | $15.89 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105293583 | CMS |
| Axsome Therapeutics, Inc. | $15.63 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148324093 | CMS |
| Currax Pharmaceuticals LLC | $14.13 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089516132 | CMS |
| GlaxoSmithKline, LLC. | $14.84 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116357678 | CMS |
| GlaxoSmithKline, LLC. | $17.93 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116341702 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.47 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143297910 | CMS |
| Lilly USA, LLC | $21.70 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135448537 | CMS |
| Lilly USA, LLC | $14.38 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135472651 | CMS |
| Lilly USA, LLC | $13.23 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135472653 | CMS |
| Nevro Corp. | $14.63 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130773843 | CMS |
| Novo Nordisk Inc | $14.94 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096593812 | CMS |
| Novo Nordisk Inc | $16.14 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097416096 | CMS |
| PFIZER INC. | $24.37 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131453285 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.